Evidently, this does not only apply to in vivo studies using tissue-specific ablation of GPX4, but also to other ferroptosis-related disease models, such as tissue ischemia/reperfusion injury, intoxication, neurodegeneration and cancer. This evidence concerns the gene GPX4 and cancer.